Metabolic & Cardiometabolic
Part of Biotech - Drug Development
 LLY | Eli Lilly & Co. | $1.1t | $1174.75 | +0.6% | 2.2M |
 AZN | AstraZeneca PLC | $294.1b | $168.30 | +0.2% | 1.8M |
 MDGL | Madrigal Pharmaceuticals, Inc. Common Stock | $12.4b | $545.82 | +1.4% | 283.4K |
 PTGX | Protagonist Therapeutics, Inc | $7.9b | $140.96 | +6.5% | 402.9K |
 TERN | Terns Pharmaceuticals, Inc. Common Stock | $6.1b | $52.97 | +0.0% | 2.3M |
 TVTX | Travere Therapeutics, Inc. Common Stock | $5.3b | $56.20 | +2.5% | 1.3M |
 KNSA | Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares | $4.9b | $64.00 | +4.8% | 618.5K |
 VKTX | Viking Therapeutics, Inc | $4.5b | $37.00 | +1.9% | 1.5M |
 NAMS | NewAmsterdam Pharma Company N.V. Ordinary Shares | $4.0b | $31.71 | +2.0% | 618.2K |
 MBX | MBX Biosciences, Inc. Common Stock | $2.6b | $63.29 | +7.8% | 812.0K |
 MLYS | Mineralys Therapeutics, Inc. Common Stock | $2.4b | $27.15 | 0.0% | 506.5K |
 MAZE | Maze Therapeutics, Inc. Common Stock | $1.7b | $28.82 | +3.5% | 279.7K |
 SEPN | Septerna, Inc. Common Stock | $1.5b | $33.41 | +5.9% | 266.1K |
 MNKD | Mannkind Corporation | $1.3b | $4.04 | -0.4% | 2.9M |
 BIOA | BioAge Labs, Inc. Common Stock | $1.1b | $22.25 | +2.9% | 391.5K |
 LXRX | Lexicon Pharmaceuticals, Inc. | $1.1b | $2.40 | +6.7% | 2.1M |
 ESPR | Esperion Therapeutics, Inc. | $0.8b | $3.19 | 0.0% | N/A |
 GYRE | Gyre Therapeutics, Inc. Common Stock | $0.7b | $6.05 | -5.8% | 65.1K |
 ALT | Altimmune, Inc. Common Stock | $0.6b | $2.92 | +0.7% | 2.6M |
 RZLT | Rezolute, Inc. Common Stock (NV) | $0.5b | $4.50 | +5.3% | 934.1K |
 SGMT | Sagimet Biosciences Inc. Series A Common Stock | $477.3m | $7.74 | +2.4% | 1.2M |
 TENX | Tenax Therapeutics, Inc. | $385.9m | $15.84 | +5.3% | 746.1K |
 ORMP | Oramed Pharmaceuticals Inc. | $196.9m | $4.01 | -0.2% | 169.5K |
 MIST | Milestone Pharmaceuticals Inc. Common Shares | $166.8m | $1.22 | -4.8% | 1.4M |
 VTVT | vTv Therapeutics Inc. Class A Common Stock | $148.3m | $32.88 | +1.5% | 76.1K |
 GUTS | Fractyl Health, Inc. Common Stock | $126.0m | $0.82 | -4.9% | 1.4M |
 AARD | Aardvark Therapeutics, Inc. Common Stock | $125.7m | $5.69 | -7.9% | 210.0K |
 CRDL | Cardiol Therapeutics Inc. Class A Common Shares | $122.2m | $1.22 | -1.6% | 1.4M |
 VANI | Vivani Medical, Inc. Common Stock (DE) | $106.9m | $1.34 | -3.0% | 457.1K |
 BMEA | Biomea Fusion, Inc. Common Stock | $106.3m | $1.28 | +1.6% | 495.7K |
 VERU | Veru Inc. | $50.2m | $2.40 | +1.3% | 86.4K |
 ALGS | Aligos Therapeutics, Inc. Common Stock | $35.7m | $5.73 | -0.7% | 45.5K |
 GRDX | GridAI Technologies Corp. Common Stock | $31.3m | $3.64 | 0.0% | 32.1K |
 SKYE | Skye Bioscience, Inc. Common Stock | $24.4m | $0.66 | +1.0% | 95.1K |
 LPCN | Lipocine Inc. | $21.1m | $2.25 | -1.3% | 20.4K |
 NCEL | NewcelX Ltd. Ordinary Shares | $19.7m | $4.04 | +2.0% | 14.0K |
 CVKD | Cadrenal Therapeutics, Inc. Common Stock | $10.3m | $2.15 | -5.6% | 46.0K |
 CURX | Curanex Pharmaceuticals Inc Common Stock | $7.5m | $0.21 | 0.0% | 15.5K |
 MTVA | MetaVia Inc. Common Stock | $7.4m | $1.82 | -4.4% | 95.4K |
 TCRT | Alaunos Therapeutics, Inc. Common Stock | $5.5m | $2.23 | 0.0% | 2.7K |
 ELAB | PMGC Holdings Inc. Common Stock | $5.5m | $1.07 | -1.4% | 1.3M |
 GLMD | Galmed Pharmaceuticals Ltd. | $4.3m | $0.52 | -1.0% | 305.3K |